These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22816077)

  • 1. Behavioral effects of original tetrapeptide, an analog of N-terminal nociceptin fragment.
    Ivanova EA; Sarycheva NY; Dubynin VA; Malyshev AV; Kalikhevich VN; Ardemasova ZA; Kamensky AA
    Bull Exp Biol Med; 2012 Jun; 153(2):177-81. PubMed ID: 22816077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of neurotropic activity exorphins--derivatives of dietary proteins].
    Dubynin VA; Asmakova LS; Sokhanenkova NIu; Bespalova ZhD; Nezavibat'ko VN; Kamenskiĭ AA
    Biull Eksp Biol Med; 1998 Feb; 125(2):153-7. PubMed ID: 9559125
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of new nociceptin analogs on the behavior of white rats.
    Chesnokova EA; Anokhin PK; Voronkova AS; Sarycheva NY; Dubynin VA; Kamenskii AA; Andreeva LA; Myasoedov NF
    Dokl Biol Sci; 2013 Mar; 449():85-8. PubMed ID: 23652434
    [No Abstract]   [Full Text] [Related]  

  • 4. A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10.
    Bobrova I; Vlaskovska M; Kasakov L; Surovoy A; Egorova N; Johansson L; Karsnas P; Terenius L
    Eur J Med Chem; 2003; 38(7-8):687-94. PubMed ID: 12932899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.
    Guerrini R; Calo G; Rizzi A; Bianchi C; Lazarus LH; Salvadori S; Temussi PA; Regoli D
    J Med Chem; 1997 Jun; 40(12):1789-93. PubMed ID: 9191955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies.
    Rizzi A; Salis MB; Ciccocioppo R; Marzola G; Bigoni R; Guerrini R; Massi M; Madeddu P; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):450-6. PubMed ID: 12070758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
    Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
    J Med Chem; 1998 Aug; 41(18):3360-6. PubMed ID: 9719588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nociceptin(1-17) fragments and its tyrosine-substituted derivative on morphine-withdrawal signs in rats.
    Kotlinska J; Dylag T; Rafalski P; Talarek S; Kosior M; Silberring J
    Neuropeptides; 2004 Oct; 38(5):277-82. PubMed ID: 15464192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats.
    Redrobe JP; Calo G; Guerrini R; Regoli D; Quirion R
    Br J Pharmacol; 2000 Dec; 131(7):1379-84. PubMed ID: 11090110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of an original analog of the C-terminal fragment of vasopressin on the behavior of white rats].
    Ponomareva NS; Voskresenskaia OG; Kamenskiĭ AA; Golubovich VP; Ashmarin IP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(3):471-7. PubMed ID: 9700911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of nociceptin analogs on scopolamine-induced memory impairment in mice.
    Miwa M; Shinki C; Uchida S; Hiramatsu M
    Eur J Pharmacol; 2009 Jan; 602(2-3):328-33. PubMed ID: 19059236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the biological effects of chemical substances on albino rat offspring].
    Rukavishnikov VS; Sosedova LM; Kapustina EA
    Gig Sanit; 2011; (6):61-3. PubMed ID: 22250396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the rat.
    Champion HC; Kadowitz PJ
    Life Sci; 1997; 61(26):PL 403-8. PubMed ID: 9416781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).
    Kotlińska J; Suder P; Sciubisz A; Łegowska A; Eilmes J; Rolka K; Silberring J
    Eur J Pharmacol; 2001 May; 419(1):33-7. PubMed ID: 11348627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test.
    Erb K; Liebel JT; Tegeder I; Zeilhofer HU; Brune K; Geisslinger G
    Neuroreport; 1997 May; 8(8):1967-70. PubMed ID: 9223086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice.
    Sakurada T; Sakurada S; Katsuyama S; Hayashi T; Sakurada C; Tan-No K; Johansson H; Sandin J; Terenius L
    Neurosci Lett; 2000 Jan; 279(1):61-4. PubMed ID: 10670788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of vestibular function by nociceptin/orphanin FQ: an in vivo and in vitro study.
    Sulaiman MR; Niklasson M; Tham R; Dutia MB
    Brain Res; 1999 May; 828(1-2):74-82. PubMed ID: 10320726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution conformation of nociceptin.
    Salvadori S; Picone D; Tancredi T; Guerrini R; Spadaccini R; Lazarus LH; Regoli D; Temussi PA
    Biochem Biophys Res Commun; 1997 Apr; 233(3):640-3. PubMed ID: 9168905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.
    Devine DP; Watson SJ; Akil H
    Neuroscience; 2001; 102(3):541-53. PubMed ID: 11226692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.